New award for imatinib mesylate tablets with golden state medical supply, INC. Period of performance is 02/27/2022 through 02/26/2023 with four, one-year option periods.

Active Indefinite Delivery Contract Awarded Last action

Contract number
36E79722D0001
Awardee
Awarding agency
Task orders
0

Award facts

Opportunity
Last date to order 94% complete
IDV ceiling
$13,958,283.00
Award type
Single award
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price

Award details come from SAM.gov/FPDS.

About this IDV

The Department of Veterans Affairs National Acquisition Center awarded a single-award indefinite-delivery contract to Golden State Medical Supply, Inc. for Imatibib Mesylate Tablets with a ceiling value of $13,958,283.00 and an award date of February 27, 2022. The contract carries no set-aside designation.

Place of performance is not specified in the source. The originating solicitation, posted July 30, 2021, was for pharmaceutical supply of Imatinib Mesylate Tablets. The period of performance runs from February 27, 2022 through February 26, 2023, with four one-year option periods extending the ultimate completion date to February 26, 2027. The contract uses NAICS 325412 (Pharmaceutical Preparation Manufacturing) and PSC 6505 (Drugs and Biologicals). The award included a modification adding diversity and equity inclusion language. No recent task-order activity is identified in the source.

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00008 · Add DEI language modification $0
Other Administrative Action P00009 · Modification P00009 is issued to recognize golden state medical supply, INC.'S change from a small business to a large business in accordance with far… $0
Other Administrative Action P00007 · Administrative and sales POC change $0
Exercise an Option P00006 · Exercise option year 4 - 36E79722D0001 golden state medical supply, INC. Imatinib mesylate tablets 02/27/2026 - 02/26/2027. $0
Exercise an Option P00005 · Exercise option year 3 - 36E79722D0001 golden state medical supply, INC. Imatinib mesylate tablets $0
Supplemental Agreement for work within scope P00004 · 52.212-4(C) contract terms and conditions - changes update to cost recovery fee (CRF) and submission of quarterly sales reports 36E79722D0001 golden state… $0
Exercise an Option P00003 · Exercise the second option year for imatinib mesylate tablets contract 36E79722D0001 with golden state medical supply. $0
Other Administrative Action P00002 · Incorporation of drug supply chain security act (DSCSA) language $0
Exercise an Option P00001 · Exercise option year 1 effective 02/27/2023 through 02/26/2024 for imatinib mesylate tablets with golden state medical supply, INC. Prices remain unchanged. $0
Original award $0

Quick answers

Who was awarded contract 36E79722D0001?

36E79722D0001 was awarded to Golden State Medical Supply, Inc. by National Acquisition Center (Headquarters) on February 27, 2022.

How much is contract 36E79722D0001 worth?

36E79722D0001's own ceiling is $13,958,283.

Who can order from contract 36E79722D0001?

36E79722D0001 is a single award indefinite delivery contract.

Was contract 36E79722D0001 competed?

The extent of competition for 36E79722D0001 was full and open competition. The government received 3 offers.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV